Gary A. Truitt

1.1k total citations · 1 hit paper
15 papers, 961 citations indexed

About

Gary A. Truitt is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Gary A. Truitt has authored 15 papers receiving a total of 961 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Gary A. Truitt's work include Immune Cell Function and Interaction (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immune Response and Inflammation (3 papers). Gary A. Truitt is often cited by papers focused on Immune Cell Function and Interaction (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immune Response and Inflammation (3 papers). Gary A. Truitt collaborates with scholars based in United States, Switzerland and Canada. Gary A. Truitt's co-authors include Emile E. Voest, Judah Folkman, Robert J. D’Amato, M. OʼReilly, Robert R. Rich, Susan Solliday Rich, Dylan R. Edwards, Colleen D. McDermott, Helen Y. Zou and Nissi Varki and has published in prestigious journals such as The Journal of Immunology, JNCI Journal of the National Cancer Institute and Annals of the New York Academy of Sciences.

In The Last Decade

Gary A. Truitt

15 papers receiving 918 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of Angiogenesis In Vivo by Interleukin 12

1995 614 citations Emile E. Voest, M. OʼReilly et al. JNCI Journal of the National Cancer Institute profile →

Peers

Countries citing papers authored by Gary A. Truitt

Since Specialization

Citations

This map shows the geographic impact of Gary A. Truitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary A. Truitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary A. Truitt more than expected).

Fields of papers citing papers by Gary A. Truitt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary A. Truitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary A. Truitt. The network helps show where Gary A. Truitt may publish in the future.

Co-authorship network of co-authors of Gary A. Truitt

This figure shows the co-authorship network connecting the top 25 collaborators of Gary A. Truitt. A scholar is included among the top collaborators of Gary A. Truitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary A. Truitt. Gary A. Truitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Broad Antitumor and Antiangiogenic Activities of AG3340, a Potent and Selective MMP Inhibitor Undergoing Advanced Oncology Clinical Trials 1999 ·Annals of the New York Academy of Sciences ·David R. Shalinsky, (unknown), Helen Y. Zou, Colleen D. McDermott, Peter Forsyth, Dylan R. Edwards, Stephen A. Margosiak, Sabine Bender, Gary A. Truitt, Alexander W. Wood, Nissi Varki, Krzysztof Appelt	202
2	Inhibition of Angiogenesis In Vivo by Interleukin 12 breakdown → 1995 ·JNCI Journal of the National Cancer Institute ·Emile E. Voest, (unknown), M. OʼReilly, Gary A. Truitt, Robert J. D’Amato, Judah Folkman	614
3	Effect of 1,25,28-trihydroxyvitamin D2 and 1,24,25-trihydroxyvitamin D3 on intestinal calbindin-D9K mRNA and protein: Is there a correlation with intestinal calcium transport? 1993 ·Journal of Bone and Mineral Research ·(unknown), Hong Li, M E Bruns, Milan R. Uskoković, Gary A. Truitt, R.L. Horst, Timothy A. Reinhardt, Sylvia Christakos	21
4	Effects of vitamin D derivatives on soft tissue calcification in neonatal and calcium mobilization in adult rats 1989 ·Archives of Toxicology ·Andreas D. Kistler, (unknown), Ronald L. Horst, Gary A. Truitt, Milan R. Uskoković	5
5	Elimination of L5178Y cells from tumor-dormant DBA/2 mice by specific active immunotherapy. 1983 ·PubMed ·(unknown), Michael K. Robinson, Gary A. Truitt, Ε. Frederick Wheelock	6
6	Enhanced suppressor macrophage activity associated with termination of the L5178Y cell tumor-dormant state in DBA/2 mice. 1983 ·PubMed ·Michael K. Robinson, Gary A. Truitt, T Okayasu, Ε. Frederick Wheelock	11
7	Cytotoxic T lymphocytes in DBA/2 mice harboring L5178Y cells in a tumor-dormant state 1983 ·Cancer Immunology Immunotherapy ·(unknown), Michael K. Robinson, Gary A. Truitt, Ε. Frederick Wheelock	6
8	Establishment and control of the L5178Y-cell tumor dormant state in DBA/2 mice 1982 ·Cancer and Metastasis Reviews ·Ε. Frederick Wheelock, Michael K. Robinson, Gary A. Truitt	3
9	Regulation of Cytotoxic Lymphocyte Responses in New Zealand Mice by Alloantigen-Activated Spleen Cells 1979 ·The Journal of Immunology ·David P. Huston, Robert R. Rich, Alfred D. Steinberg, Gary A. Truitt	8
10	Requlation of cytotoxic lymphocyte responses in New Zealand mice by alloantigen-activated spleen cells. 1979 ·PubMed ·David P. Huston, Robert R. Rich, Alfred D. Steinberg, Gary A. Truitt	15
11	Interaction between T Cells and Non-T Cells in Suppression of Cytotoxic Lymphocyte Responses 1979 ·The Journal of Immunology ·Gary A. Truitt, David Dennison, Robert R. Rich, Susan Solliday Rich	13
12	Suppressor T cells in the regulation of immune responses to allogeneic tissues. 1978 ·PubMed ·R R Rich, Stephen S. Rich, Gary A. Truitt	2
13	Suppression of Cytotoxic Lymphocyte Responses in Vitro by Soluble Products of Alloantigen-Activated Spleen Cells 1978 ·The Journal of Immunology ·Gary A. Truitt, Robert R. Rich, Susan Solliday Rich	22
14	Regulation of Cytotoxic Lymphocyte Responses in Vitro by Alloantigen-Activated Spleen Cells 1977 ·The Journal of Immunology ·Gary A. Truitt, Robert R. Rich, Susan Solliday Rich	24
15	Role of cellular density, in vitro, in anti-tumor activity of CFA-treated and immunized cells 1976 ·Inflammation Research ·Edwin M. Uyeki, Gary A. Truitt, (unknown)	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact